Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.57 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.39 |
| ▸ | SHBG | P04278 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8470006 | 1.00 | TYR (0.57) | TYRAMY1AMEN1KMT2AMAPT | |
| SCHEMBL10446211 | 0.88 | AMY1A (0.52) | TYRAMY1AMEN1KMT2AMAPT | |
| SCHEMBL8066841 | 0.88 | AMY1A (0.67) | TYRAMY1AMEN1KMT2AMAPT | |
| SCHEMBL16451675 | 0.84 | TYR (0.45) | TYRAMY1AMEN1KMT2AMAPT | |
| SCHEMBL10011371 | 0.83 | BCL2 (0.53) | TYRMEN1KMT2AHIF1AALOX15 | |
| SCHEMBL9644973 | 0.83 | TYR (0.47) | TYRAMY1AMEN1KMT2AMAPT | |
| SCHEMBL18744075 | 0.83 | KEAP1 (0.50) | TYRMEN1KMT2AMAPTESR1 | |
| SCHEMBL28845277 | 0.83 | TYR (0.55) | TYRAMY1AMEN1KMT2AMAPT | |
| SCHEMBL70108 | 0.83 | TYR (0.60) | TYRMEN1KMT2AMAPTSHBG | |
| SCHEMBL4063406 | 0.82 | TYR (0.44) | TYRAMY1AMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565930-B2 | Seal member and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2026-03-03 | — | — | US | disclosed |
| US-20240337317-A1 | SEAL MEMBER AND PRODUCTION METHOD THEREOF | CANON KABUSHIKI KAISHA (JP) | 2024-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565930-B2 | Seal member and production method thereof | RIPK1, SLK, STK39 | TYR 4202/4885AMY1A 3509/4885MEN1 4536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.